It was reported that Alox5 deficiency resulted in a significant reduction of LSCs in BM, and thus largely prolonged survival of BCR-ABL-induced CML mice26. This evidence concerns the gene ALOX5 and chronic myelogenous leukemia, BCR-ABL1 positive.